ResearcherUniversity Health NetworkNo recent work listed
Eitan Amir
Matched on ORCID iD 0000-0002-3706-525X; OpenAlex author ID A5102844847. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2017: 1 paper · 2018: none · 2019: 2 papers · 2020: none · 2021: 1 paper
Papers 4
- Genomic sequencing to inform therapy in advanced pancreatic cancer: A systematic review and meta-analysis of prospective studies. Co-author DOI 10.1016/j.ctrv.2021.102310↗
- Adjuvant chemotherapy and outcomes in patients with nodal and resection margin-negative pancreatic ductal adenocarcinoma: A systematic review and meta-analysis. Co-author DOI 10.1002/jso.25440↗
- Response to letter to the editor: The impact of the nodal status and resection margin on the effectiveness of adjuvant chemotherapy for pancreatic cancer: It c… First author DOI 10.1002/jso.25691↗
- Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis. Co-author DOI 10.3390/ijms18050909↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mairead Geraldine McNamara · 3 shared papers, 2017–2019 · strength 0.39
- Paper Response to letter to the editor: The impact of the nodal status and resection margin on the effectiveness of adjuvant … DOI 10.1002/jso.25691↗
- Paper Adjuvant chemotherapy and outcomes in patients with nodal and resection margin-negative pancreatic ductal adenocarcinom… DOI 10.1002/jso.25440↗
- Paper Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer:… DOI 10.3390/ijms18050909↗
- Richard A Hubner · 2 shared papers, 2017–2019 · strength 0.19
- Paper Adjuvant chemotherapy and outcomes in patients with nodal and resection margin-negative pancreatic ductal adenocarcinom… DOI 10.1002/jso.25440↗
- Paper Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer:… DOI 10.3390/ijms18050909↗
- Juan W. Valle · 2 shared papers, 2017–2019 · strength 0.19
- Paper Adjuvant chemotherapy and outcomes in patients with nodal and resection margin-negative pancreatic ductal adenocarcinom… DOI 10.1002/jso.25440↗
- Paper Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer:… DOI 10.3390/ijms18050909↗
- Nicola Flaum · 1 shared paper, 2019 · strength 0.12
- Michael J. Allen · 1 shared paper, 2021 · strength 0.12
- Ravi Ramjeesingh · 1 shared paper, 2021 · strength 0.12
- Nicholas Meti · 1 shared paper, 2021 · strength 0.12
- Robert C. Grant · 1 shared paper, 2021 · strength 0.12
- Grainne Mary O'Kane · 1 shared paper, 2021 · strength 0.12
- Jennifer Jane Knox · 1 shared paper, 2021 · strength 0.12
- Steve Gallinger · 1 shared paper, 2021 · strength 0.12
- Faiyaz Notta · 1 shared paper, 2021 · strength 0.12
- George Zogopoulos · 1 shared paper, 2021 · strength 0.12
- Jaseela Chiramel · 1 shared paper, 2017 · strength 0.07
- Ángela Lamarca Lete · 1 shared paper, 2017 · strength 0.07
- Rille Pihlak · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.